EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Navigating the Global Regulatory Landscape for Exosome-Based Therapeutics: Challenges, Strategies, and Future Directions

Nagendra Verma iD, Swati Arora

Pharmaceutics · 30.07.2025 · 17 (8) · 990

DOI: 10.3390/pharmaceutics17080990 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 30.07.2025. Verfasst von Nagendra Verma und 1 weiteren Autor:innen. Beteiligte Einrichtung: Applied Education in the MedTech Industry, St. Cloud State University, Plymouth, MN 55442, USA. Die Arbeit wurde bisher 174-mal zitiert (Crossref) und nennt 114 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Extracellular vesicle (EV)-based therapies have attracted considerable attention as a novel class of biologics with broad clinical potential. However, their clinical translation is impeded by the fragmented and rapidly evolving regulatory landscape, with significant disparities between the United States, European Union, and key Asian jurisdictions. In this review, we systematically analyze regional guidelines and strategic frameworks governing EV therapeutics, emphasizing critical hurdles in quality control, safety evaluation, and efficacy demonstration. We further explore the implications of EVs’ heterogeneity on product characterization and the emerging direct-to-consumer market for EVs and secretome preparations. Drawing on these insights, in this review, we aim to provide a roadmap for harmonizing regulatory requirements, advancing standardized analytical approaches, and fostering ongoing collaboration among regulatory authorities, industry stakeholders, and academic investigators. Such coordinated efforts are essential to safeguard patient welfare, ensure product consistency, and accelerate the responsible integration of EV-based interventions into clinical practice.

Schlagwörter

Stichwörter der Autor:innen

clinical translationexosomesextracellular vesiclesglobal regulatory harmonizationmanufacturing scalabilityquality controlregulatory frameworkstandardizationtherapeutics

Autor:innen und Institutionen

  • Applied Education in the MedTech Industry, St. Cloud State University, Plymouth, MN 55442, USA.
  • Department of Chemistry, University of Pittsburgh, 219 Parkman Ave, Pittsburgh, PA 15260, USA.

ORCID-Profile: Nagendra Verma

Zitieren

APA

Verma, N., & Arora, S. (2025). Navigating the Global Regulatory Landscape for Exosome-Based Therapeutics: Challenges, Strategies, and Future Directions. Pharmaceutics, 17(8), 990. https://doi.org/10.3390/pharmaceutics17080990

Vancouver

Verma N, Arora S. Navigating the Global Regulatory Landscape for Exosome-Based Therapeutics: Challenges, Strategies, and Future Directions. Pharmaceutics. 2025;17(8):990. doi:10.3390/pharmaceutics17080990

BibTeX
@article{Verma2025,
  author = {Verma, Nagendra and Arora, Swati},
  title = {Navigating the Global Regulatory Landscape for Exosome-Based Therapeutics: Challenges, Strategies, and Future Directions},
  journal = {Pharmaceutics},
  year = {2025},
  volume = {17},
  number = {8},
  pages = {990},
  doi = {10.3390/pharmaceutics17080990}
}
Kostenlos starten →